We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-4.58%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$38.3B
AUM Growth
+$10.8B
Cap. Flow
+$12.9B
Cap. Flow %
33.6%
Top 10 Hldgs %
9.4%
Holding
4,435
New
2,018
Increased
1,007
Reduced
916
Closed
371

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$302M
2
ADBE icon
Adobe
ADBE
+$291M
3
AMZN icon
Amazon
AMZN
+$266M
4
MSFT icon
Microsoft
MSFT
+$257M
5
LLY icon
Eli Lilly
LLY
+$214M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$192M
2
CB icon
Chubb
CB
+$160M
3
AMD icon
Advanced Micro Devices
AMD
+$144M
4
DIS icon
Walt Disney
DIS
+$134M
5
CVS icon
CVS Health
CVS
+$132M

Sector Composition

Rank Sector Weight
1 Technology 19.59%
2 Consumer Discretionary 12.46%
3 Financials 10.63%
4 Industrials 10.62%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRIN
3901
DELISTED
Marin Software
MRIN
$15 ﹤0.01%
+6
New +$21
ZENV
3902
DELISTED
Zenvia
ZENV
$15 ﹤0.01%
+14
New +$13
MKUL
3903
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$15 ﹤0.01%
+101
New +$150
ACOR
3904
DELISTED
Acorda Therapeutics
ACOR
$15 ﹤0.01%
+1
New +$15
CODX
3905
Co-Diagnostics
CODX
$7.52M
– –
0
– –
SATX
3906
DELISTED
SatixFy Communications
SATX
$14 ﹤0.01%
+27
New +$13
TKLF
3907
Yoshitsu Co
TKLF
$8.72M
$14 ﹤0.01%
+1
New +$11
BCEL
3908
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$14 ﹤0.01%
+52
New +$33
ANIX icon
3909
Anixa Biosciences
ANIX
$118M
$13 ﹤0.01%
+4
New +$14
CRIS icon
3910
Curis
CRIS
$9.14M
– –
0
– –
DRIO icon
3911
DarioHealth
DRIO
$54.6M
– –
0
– –
CSSE
3912
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$13 ﹤0.01%
+38
New +$28
DLA
3913
DELISTED
Delta Apparel Inc.
DLA
$13 ﹤0.01%
+2
New +$16
FBIO icon
3914
Fortress Biotech
FBIO
$109M
$12 ﹤0.01%
+3
New +$21
TLIS
3915
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$12 ﹤0.01%
+2
New +$14
CULP icon
3916
Culp Inc
CULP
$45.5M
$11 ﹤0.01%
+2
New +$11
GYRE icon
3917
Gyre Therapeutics
GYRE
$683M
$11 ﹤0.01%
+1
New +$7
JFU
3918
9F Inc
JFU
$23.5M
$11 ﹤0.01%
+4
New +$13
JG
3919
Aurora Mobile
JG
$28.5M
$11 ﹤0.01%
+4
New +$17
NUWE icon
3920
Nuwellis
NUWE
$183K
– –
0
– –
PSNL icon
3921
Personalis
PSNL
$1.28B
$11 ﹤0.01%
+9
New +$16
CYT
3922
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$11 ﹤0.01%
+4
New +$11
AEYE icon
3923
AudioEye
AEYE
$74.7M
$10 ﹤0.01%
+2
New +$10
GNLN icon
3924
Greenlane Holdings
GNLN
$1.22M
– –
0
– –
WORX
3925
DELISTED
SCWORX CORP NEW
WORX
– –
0
– –
155 156
157
158 159

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q3 2023 Portfolio in Review

As of Q3 2023, Qube Research & Technologies (QRT) held 4,435 positions worth $38.3B, up 39% from $27.5B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Qube Research & Technologies (QRT) deployed $12.9B of net new capital in Q3 2023, opening 2,018 new positions and adding to 1,007 existing holdings. Its largest new stake was Eli Lilly: 415,473 shares worth $223M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $192M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q3 2023 buy was Eli Lilly: 415,473 shares worth $223M.
  • Qube Research & Technologies (QRT) added most to Johnson & Johnson in Q3 2023, an estimated $302M increase.
  • Qube Research & Technologies (QRT)'s biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $192M.
  • Qube Research & Technologies (QRT) fully exited Walt Disney in Q3 2023, selling an estimated $134M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 9.4% of its $38.3B portfolio in Q3 2023.
  • Qube Research & Technologies (QRT) opened 2,018 new positions and closed 371 in Q3 2023.
  • Qube Research & Technologies (QRT)'s portfolio value rose 39% quarter-over-quarter to $38.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2023, filed 13 Nov 2023.